EcoDrugPlus

Dopamine Receptor D2

Ensembl ID : ENSJJAG00000011634
Gene Symbol: DRD2
3 Cross references
219 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSJJAG00000018298
Gene Symbol: DRD3
3 Cross references
206 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSJJAG00000023314
Gene Symbol: DRD4
3 Cross references
246 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSJJAG00000001919
Gene Symbol: ENPP2
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSJJAG00000014701
Gene Symbol: EGLN2
2 Cross references
190 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSJJAG00000013045
Gene Symbol: EGLN3
3 Cross references
206 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSJJAG00000011431
Gene Symbol: ELANE
1 Cross references
102 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSJJAG00000023176
Gene Symbol: EPAS1
3 Cross references
222 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSJJAG00000011915
Gene Symbol: ECE1
3 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSJJAG00000019465
Gene Symbol: EDNRA
3 Cross references
264 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSJJAG00000013624
Gene Symbol: EDNRB
3 Cross references
264 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSJJAG00000014722
Gene Symbol: EZH2
3 Cross references
222 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).